Obesity challenges the hepatoprotective function of the integrated stress response to asparaginase exposure in mice

Inna A Nikonorova1, Rana J T Al-Baghdadi2, Emily T Mirek1

  • 1From the Department of Nutritional Sciences, and.

Insights

Obesity worsens liver toxicity from asparaginase by disrupting the integrated stress response (ISR). GCN2 normally represses mTORC1, but its loss in obesity unleashes mTORC1, causing liver dysfunction and impacting protein and hydrogen sulfide levels.

Area of Science:

  • Biochemistry
  • Cellular Biology
  • Toxicology

Background:

  • Obesity exacerbates liver toxicity induced by the anti-leukemic drug asparaginase through unknown mechanisms.
  • Asparaginase triggers the integrated stress response (ISR) by activating the GCN2 kinase due to amino acid depletion.

Purpose of the Study:

  • To investigate how obesity, with or without ISR genetic disruption, affects liver protection during chronic asparaginase treatment in mice.
  • To elucidate the specific roles of GCN2 and PERK in mediating asparaginase-induced liver toxicity in obese mice.

Main Methods:

  • Diet-induced obesity model in mice.
  • Biochemical analysis of liver tissues.
  • Genetic manipulation of ISR components (Gcn2, Atf4).
  • Measurement of ISR gene targets, mTORC1 signaling, hydrogen sulfide production, and apolipoprotein B100 expression.

Main Results:

  • Obesity promoted hepatic steatosis and PERK activation upon asparaginase exposure.
  • Loss of GCN2 intensified PERK activation but paradoxically reduced ISR gene expression, leading to mTORC1 activation and liver dysfunction.
  • Mice lacking Atf4 exhibited an exaggerated ISR and reduced hydrogen sulfide but maintained normal mTORC1 signaling and ApoB100 expression.
  • Asparaginase increased Sestrin2, but this did not appear to mediate mTORC1 inhibition via the eIF2-ATF4-Sestrin2 pathway.

Conclusions:

  • Obesity promotes a detrimental ISR during asparaginase therapy.
  • GCN2 plays a crucial role in suppressing mTORC1 activity and maintaining ApoB100 levels, independent of Atf4.
  • The GCN2-ATF4 pathway is essential for promoting hydrogen sulfide production during asparaginase treatment.